Drug Identification Numbers (DINs)

Drug Identification Numbers (DINs) are numbers assigned to medications marketed in Canada by Health Canada.

Below you’ll find those pesky DIN numbers that your patients are always seeking for their insurance coverage.

• Abatacept IV (Orencia): 02282097
• Abatacept SC (Orencia): 02402475
• Adalimumab (Humira): 02258595
• Anakinra (Kineret): 02245913
• Belimumab (Benlysta): 02370050, 02370069
• Certolizumab (Cimzia): 02331675
• Denosumab (Prolia): 02343541
• Depomedrol: 00030759 (40 mg/mL), 00030767 (80 mg/mL)
• Etanercept (Enbrel): 02274728, 02242903
• Golimumab SC (Simponi): 02324784, 02324776
• Golimumab IV (Simponi): 02324776
• Infliximab (Remicade): 02244016
• Infliximab (Remsima): 02419483
• Rituximab (Rituxan): 02241927
• Tocilizumab IV (Actemra): 02350092, 02350106, 02350114
• Tocilizumab SC (Actemra): 02424770
• Tofacitinib (Xeljanz): 02423898
• Viscosupplementation: 00000962325, 00000965294 (Synvisc), 00000965014 (Synvisc One), 00000963828 (Neovisc), 00000964573 (Durolane), 00096599996 (Euflexxa), 00000963631 (Suplasyn), 00000174625 (Orthovisc)

IV = Intravenous, SC = subcutaneous injection